InsiderTrades.com logo
30 Days of MarketBeat All Access for $1.00
From MarketBeat   |   Ad
Access our premier stock research platform that includes research tools, stock screeners, instant alerts, real-time news and much more.
Start Your 30-Day Risk-Free Trial Subscription Here

PLXP Insider Trading (PLx Pharma)

Insider Ownership Percentage: 9.42%
Insider Buying (Last 12 Months): $1,342,169.50
Insider Selling (Last 12 Months): $0.00

PLx Pharma Insider Trading History Chart

PLx Pharma Share Price & Price History

$12.23
▼ -0.29 (-2.32%)
As of 06/21/2021 04:51 PM ET
Days: 30 | 90 | 365
We're pulling 69%/yr — without margin, options, or gimmicks
From Investing Daily   |   Ad
I only buy one kind of stock. 37 of these cash cows are in my portfolio right now... and for every dollar invested in them they are sending us 69 cents in dividends. That's an effective yield of 69% a year-every year. All without leverage, options, or gimmicks.
Details here.
pixel

PLx Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/14/2021Michael J ValentinoChairmanBuy8,000$12.48$99,840.00487,890View SEC Filing Icon  
3/5/2021Michael J ValentinoChairmanBuy25,000$8.00$200,000.00486,690View SEC Filing Icon  
12/14/2020John HaddenDirectorBuy1,000$5.45$5,450.003,290View SEC Filing Icon  
11/18/2020Michael J ValentinoChairmanBuy264,900$3.79$1,003,971.00461,690View SEC Filing Icon  
9/1/2020Rita M O'connorCFOBuy4,500$3.74$16,830.0010,850View SEC Filing Icon  
8/21/2020Rita M O'connorCFOBuy4,050$3.97$16,078.502,300View SEC Filing Icon  
5/20/2019Michael J ValentinoInsiderBuy44,404$5.60$248,662.40View SEC Filing Icon  
12/27/2018Park West Asset Management LlcMajor ShareholderBuy397,495$1.00$397,495.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for PLx Pharma (NASDAQ:PLXP)

31.13% of PLx Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

PLx Pharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/10/2021Perceptive Advisors LLC222,180$2.01M0.0%N/A0.973%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC18,382$0.17M0.0%+19.9%0.080%Search for SEC Filing on Google Icon
5/18/2021Cubist Systematic Strategies LLC19,233$0.17M0.0%N/A0.084%Search for SEC Filing on Google Icon
5/18/2021MSD Partners L.P.1,875,000$16.93M1.2%N/A8.209%Search for SEC Filing on Google Icon
5/17/2021Perceptive Advisors LLC222,180$2.01M0.0%N/A0.973%Search for SEC Filing on Google Icon
5/17/2021Goldman Sachs Group Inc.13,658$0.12M0.0%N/A0.060%Search for SEC Filing on Google Icon
5/14/2021Laurion Capital Management LP49,680$0.45M0.0%N/A0.218%Search for SEC Filing on Google Icon
5/14/2021Friess Associates LLC303,400$2.74M1.1%N/A1.328%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC278,551$2.52M0.0%+100.3%1.220%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp10,338$93K0.0%N/A0.045%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp35,932$0.32M0.0%+257.8%0.157%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC162,496$1.47M0.0%N/A0.711%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG13,851$0.13M0.0%+497.0%0.061%Search for SEC Filing on Google Icon
5/11/2021GW&K Investment Management LLC453,921$4.10M0.0%N/A1.987%Search for SEC Filing on Google Icon
5/4/2021Commonwealth Equity Services LLC11,994$0.11M0.0%N/A0.055%Search for SEC Filing on Google Icon
4/27/2021Dorsey Wright & Associates4,342$39K0.5%N/A0.020%Search for SEC Filing on Google Icon
4/22/2021Private Advisor Group LLC23,525$0.21M0.0%N/A0.108%Search for SEC Filing on Google Icon
4/20/2021Heritage Way Advisors LLC34,000$0.31M0.1%-18.5%0.156%Search for SEC Filing on Google Icon
2/12/2021Credit Suisse AG27,394$0.15M0.0%N/A0.299%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC139,083$0.77M0.0%+79.0%1.519%Search for SEC Filing on Google Icon
4/15/2020Heritage Way Advisors LLC41,712$94K0.1%+31.5%0.456%Search for SEC Filing on Google Icon
2/10/2020University of Texas Texas AM Investment Managment Co.62,673$0.27M0.3%N/A0.685%Search for SEC Filing on Google Icon
11/27/2019Millennium Management LLC51,963$0.27M0.0%-32.1%0.568%Search for SEC Filing on Google Icon
10/30/2019Heritage Way Advisors LLC30,000$0.15M0.1%N/A0.332%Search for SEC Filing on Google Icon
8/14/2019Vanguard Group Inc.145,649$1.05M0.0%+29.2%1.642%Search for SEC Filing on Google Icon
8/13/2019BlackRock Inc.9,897$72K0.0%+150.1%0.112%Search for SEC Filing on Google Icon
8/12/2019Renaissance Technologies LLC64,711$0.47M0.0%+10.4%0.729%Search for SEC Filing on Google Icon
6/30/2019Nottingham Advisors Inc.58,584$0.42M0.1%N/A0.660%Search for SEC Filing on Google Icon
2/15/2019Millennium Management LLC57,213$88K0.0%-33.6%0.654%Search for SEC Filing on Google Icon
2/14/2019Park West Asset Management LLC1,473,218$2.25M0.1%+37.0%16.839%Search for SEC Filing on Google Icon
1/29/2019Harel Insurance Investments & Financial Services Ltd.250,000$0.38M0.0%-54.5%2.857%Search for SEC Filing on Google Icon
12/13/2018Vanguard Group Inc163,431$0.66M0.0%+98.0%1.870%Search for SEC Filing on Google Icon
11/23/2018Vanguard Group Inc.163,431$0.66M0.0%+98.0%1.870%Search for SEC Filing on Google Icon
6/28/2018Brown Advisory Inc.75,000$0.25M0.0%-31.8%0.859%Search for SEC Filing on Google Icon
5/15/2018CVI Holdings LLC46,096$0.15M0.2%N/A0.528%Search for SEC Filing on Google Icon
5/2/2018Texas Treasury Safekeeping Trust Co.58,567$0.20M0.0%N/A0.671%Search for SEC Filing on Google Icon
2/15/2018683 Capital Management LLC124,557$0.86M0.1%-50.0%1.428%Search for SEC Filing on Google Icon
2/13/2018Renaissance Technologies LLC32,512$0.22M0.0%+44.4%0.373%Search for SEC Filing on Google Icon
2/12/2018Brown Advisory Inc.110,000$0.76M0.0%N/A1.261%Search for SEC Filing on Google Icon
2/1/2018Harel Insurance Investments & Financial Services Ltd.550,000$0.36M0.0%+120.0%6.307%Search for SEC Filing on Google Icon
12/7/2017683 Capital Management LLC249,300$1.60M0.2%-14.3%2.859%Search for SEC Filing on Google Icon
11/20/2017Susquehanna International Group LLP151,900$0.99M0.0%-33.9%1.742%Search for SEC Filing on Google Icon
11/2/2017Harel Insurance Investments & Financial Services Ltd.250,000$0.15M0.0%N/A2.878%Search for SEC Filing on Google Icon
8/15/2017Susquehanna International Group LLP229,800$1.41M0.0%N/A5.243%Search for SEC Filing on Google Icon
8/3/2017University of Texas Investment Managment Co.62,673$0.39M1.1%N/A1.430%Search for SEC Filing on Google Icon
7/18/2017Heritage Way Advisors LLC32,101$0.20M0.2%N/A0.370%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
PLx Pharma logo
PLx Pharma Inc., a specialty pharmaceutical company, focuses on developing the PLxGuard drug delivery system to provide various products in the United States. The company's lead product candidates are Vazalore 325 mg and Vazalore 81 mg, which are formulations of aspirin that use the PLxGuard delivery system, which provides patients with vascular disease and diabetic patients who are candidates for aspirin therapy based on physician recommendation, with fast, reliable, and predictable platelet inhibition as compared to enteric-coated aspirin, as well as reduces the risk of stomach erosions and ulcers as compared with immediate-release aspirin, after seven days of treatment. Its product pipeline also includes other oral nonsteroidal anti-inflammatory drugs using the PLxGuard drug delivery system, such as PL1200 Ibuprofen 200 mg and PL1200 Ibuprofen 400 mg, which are in Phase I clinical stage for pain and inflammation, as well as PL1100 Ibuprofen 400 mg. PLx Pharma Inc. was founded in 2002 and is headquartered in Sparta, New Jersey.
Read More on PLx Pharma

Today's Range

Now: $12.23
$11.88
$12.88

50 Day Range

MA: $11.91
$9.69
$15.08

52 Week Range

Now: $12.23
$2.72
$16.19

Volume

5,168 shs

Average Volume

267,726 shs

Market Capitalization

$279.33 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

5.09

Who are the company insiders with the largest holdings of PLx Pharma?

PLx Pharma's top insider shareholders include:
  1. Michael J Valentino (Chairman)
  2. Rita M O'connor (CFO)
  3. John Hadden (Director)

Who are the major institutional investors of PLx Pharma?

PLx Pharma's top institutional investors include:
  1. MSD Partners L.P. — 8.21%
  2. GW&K Investment Management LLC — 1.99%
  3. Friess Associates LLC — 1.33%
  4. Renaissance Technologies LLC — 1.22%
  5. Perceptive Advisors LLC — 0.97%
  6. Perceptive Advisors LLC — 0.97%

Which institutional investors are selling PLx Pharma stock?

Within the previous quarter, PLXP stock was sold by these institutional investors:
  1. Heritage Way Advisors LLC

Which institutional investors are buying PLx Pharma stock?

During the previous quarter, PLXP stock was purchased by institutional investors including:
  1. MSD Partners L.P.
  2. GW&K Investment Management LLC
  3. Friess Associates LLC
  4. Perceptive Advisors LLC
  5. Perceptive Advisors LLC
  6. Geode Capital Management LLC
  7. Renaissance Technologies LLC
  8. Laurion Capital Management LP
Within the last year, these company insiders have bought PLx Pharma stock:
  1. Michael J Valentino (Chairman)
  2. Rita M O'connor (CFO)
  3. John Hadden (Director)
[URGENT] MAJOR BUY ALERT
From Legacy Research   |   Ad
Since 2016, Teeka Tiwari has trumped the stock market. His investment recommendations have each averaged 281%. That’s 17 times the S&P. And 112 times the average investor, according to JPMorgan!

However, one investment Teeka just uncovered could top them all… It involves former President Biden, billions of dollars, several large banks, and a super-rich family. As well as a MAJOR potential upgrade to our credit cards.

Teeka, who ended up correctly picking the last “investment of the decade,” is declaring this his top pick for the 2020s.
See Teeka's Top Pick...